PSA18 maps out the future of pharmacy
PSA18 has wrapped up in Sydney, with the future of pharmacy firmly in sight as PSA presented the Pharmacists in 2023 Discussion Paper, a...
PSA working to increase pharmacist remuneration
PSA has this week lodged two major submissions addressing pharmacist remuneration.
The first is our response to the Medicare Benefits Schedule Review Taskforce, where...
PBS listings for cancer, Parkinson’s and motor neurone disease
Since 1 April, medicines crucial to those suffering from cancer, Parkinson’s and motor neurone disease have become available on the Pharmaceutical Benefits Scheme (PBS).
The...
Opioids, antidepressants and the risk of hip fracture
A recent study identified that the risk of hip fracture was increased with the use of psychotropic drugs in elderly people. The highest risk...
I take Kakadu plum, is that ok?
How the new PSA guideline can help answer this question.
When asked about bush medicine most pharmacists would struggle. Bush medicine is a form of...
Five funding recommendations to improve medicine safety
Increased funding for pharmacists in aged care and rural and remote communities would save lives and improve health outcomes, PSA has argued in its...
